期刊文献+

地特胰岛素与甘精胰岛素联合口服降糖药治疗2型糖尿病疗效比较 被引量:3

下载PDF
导出
摘要 选取86例我院门诊初诊的2型糖尿病患者,随机分为A、B两组,每组43例。A组给予地特胰岛素晚餐前注射联合二甲双胍,如果血糖不达标者加用阿卡波糖,B组给予甘精胰岛素晚餐前注射联合二甲双胍,如果血糖不达标者加用阿卡波糖。分别对两组治疗前、治疗3个月及治疗6个月后的空腹血糖(FPG)、餐后2小时血糖(2h PG)、糖化血红蛋白(Hb A1c)、血脂(TC、TG)、血糖达标时间、胰岛素使用平均日剂量、低血糖发生率、体重变化情况进行比较。结果与治疗前比较,两组患者治疗后FPG、2h PG、Hb A1c、TC、TG均显著降低,比较差异有统计学意义(P<0.05),治疗后两组之间的比较差异均无统计学意义;两组在血糖达标时间、胰岛素使用平均日剂量、低血糖发生率比较差异无统计学意义(P>0.05);治疗后A组体重增加量少于B组,两组比较差异有统计学意义(P<0.05)。结论地特胰岛素与甘精胰岛素联合口服降糖药治疗2型糖尿病患者,均能有效控制血糖,且低血糖发生率低。相比甘精胰岛素,地特胰岛素减少体重增加更具有优势。
作者 黄华英
出处 《实用糖尿病杂志》 2015年第5期51-53,共3页 Journal of Practical Diabetology
  • 相关文献

参考文献8

二级参考文献14

  • 1中华医学会糖尿病学分会.中华医学会糖尿病学分会关于干细胞移植治疗糖尿病的立场声明[J].中华糖尿病杂志,2010,2(6). 被引量:36
  • 2张良岩,李翠华,伊婕,杨乃龙.亚莫利分别与来得时、NPH联合治疗比较[J].实用糖尿病杂志,2006,2(6):16-17. 被引量:16
  • 3Meneghini LF, Rosenberg KH, Koenen C, et al. Insulin detemir improves glycaemie control with less hypoglyeaemia and no weight gain in patientswith type 2 diabeteswho were insulin naive or treated with NPZI or insulin glargine: clinical practice experience from a German subgroup of the PRED ICTIVE study[J]. Diabetes Obes Metab,2007,9 (3) : 418-427.
  • 4Heise T, Eckers U, Kanc K, et al. The pharmacokinetic and pharmacodynamic properties of different formulations of biphasic insulin aspart : a randomized, glucose clamp, crossover study [J].Diabetes Technol Ther,21108,10 (6) : 4792485.
  • 5Rosenstock J, DaviesM, Home PD, et al. A randomised, 52 week, treat to target trial comparing insulin detemir with insulin glargine when administered as add on to glucose lowering drugs in insulin naive people with type diabetes[J]. Diabetologia,2008,51 (3) :408-416.
  • 6Floch J P, Lvy M,Mosnier P H,et a l. Comparison of once versus twice daily administration of insulin detemir, used with mealtime insulin aspart,in basalbolus therapy for type1 diabe tes: assessment of detemir administration in a progressive treat to target trial (ADAPT)E J2. Diabetes Care,2009,32 (1) : 32-37.
  • 7Fajardo MC, Rivas FM. Less weight gain and hypoglycaemia with once daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patiems: the PRED ICTIVE BMI clinical trial[J]. Diabet Med, 201)8,25 ( 8 ):916-923.
  • 8Danne T,Datz N, Endahl I.,et al. Insulin detemir is character ized by a more reproducible pharmacokinetic profile than insu lin glargine in children and adolescents with type 1 diabetes: results from a randomized, doubleblind, controlled trial[J]. Pe diatr Diabetes,2008,9 (6) : 554-560.
  • 9Yang WY, Lu JM, Weng JP, et al. Prevalence of Diabetes among men and women in China[J]. N Engl J Med,2010,362 :1090-1101.
  • 10Philis-Tsimikas A. Tolerability, safey and abherence to treatment with insulin detemir injection in the treatment type 2 diabetes [ J ]. Patient Preference and Adherence,2008,2:323-332.

共引文献6774

同被引文献36

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部